Global Vagus Nerve Stimulators Market to Surpass US$ 1,251.9 Million by 2030 – Coherent Market Insights – QNT Press Release

[ad_1]

SEATTLE, June 6, 2022 /PRNewswire/ — According to Coherent Market Insightsthe global vagus nerve stimulators market is estimated to be valued at US$ 628.3 million in 2022 and is expected to exhibit a CAGR of 9.0% over the forecast period (2022-2030).

Key Trends and Analysis of the Global Vagus Nerve Stimulators Market:

Key trends in the market include increasing prevalence of neurological disorders such as epilepsy, depression, anxiety, migraine, among others; increasing approval of novel products, and increasing collaborations, acquisitions, and partnerships among key players. These key trends are expected to aid in growth of the global vagus nerve stimulators market.

According to an article published by The Scientific World Journal, a peer-reviewed, open access journal, in June 2020it is estimated that migraine prevalence ranged between 2.6% and 32% among the general population in Arab countries (such as Bahrain, Iraq, Jordanetc.), in 2019. The same source also estimates that the prevalence of migraine headache among school children of age group 6 to 18 years ranged between 7.1% and 13.7% and between 12.2% and 27.9% in medical university students in Arab countries in 2019.

Moreover, increasing approvals of novel vagus nerve stimulator products are expected to drive the market growth over the forecast period. For instance, in January 2022electroCore, Inc., a US based medical technology company announced that it has received the Breakthrough Device Designation from the US Food and Drug Administration (FDA) for its gammaCore Non-Invasive Vagus Nerve Stimulation(nVNS) for the treatment of post-traumatic stress disorder (PTSD).

Furthermore, key players operating in the global

Full story available on Benzinga.com

[ad_2]

Source link

Recommended For You

About the Author: News Center